LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Respiratory Hypersensitivity D012130 18 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Enteritis D004751 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Influenza, Human D007251 11 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Woszczek G et al. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. 2010 J. Immunol. pmid:20083671
Schäper C et al. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis. 2009 J Investig Allergol Clin Immunol pmid:20128420
Zhou G et al. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway. 2010 Cardiology pmid:20234134
Julius P et al. sCD14 in bronchoalveolar lavage 18, 42 and 162 hours after segmental allergen provocation. 2010 Scand. J. Immunol. pmid:20384875
Wunder F et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. 2010 Br. J. Pharmacol. pmid:20423349
Lieber G et al. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat. 2010 Pharmacology pmid:20453555
Li R et al. [Analysis of the nasopharyngeal aspirates in children with different severities of bronchiolitis]. 2010 Zhongguo Dang Dai Er Ke Za Zhi pmid:20497653
Kim MH et al. Effect of leukotriene D4 on mouse embryonic stem cell migration and proliferation: involvement of PI3K/Akt as well as GSK-3β/β-catenin signaling pathways. 2010 J. Cell. Biochem. pmid:20589831
Sakai H et al. Augmented venous responsiveness to leukotriene D(4) in nasal septal mucosae of repeatedly antigen-challenged rats. 2010 Eur. J. Pharmacol. pmid:20638382
Zhou Y et al. Circulating LTD4 in patients with hepatocellular carcinoma. 2011 Tumour Biol. pmid:20820981
Hayashi S et al. Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. 2010 Bioorg. Med. Chem. pmid:20875743
McGovern T et al. LTDâ‚„ induces HB-EGF-dependent CXCL8 release through EGFR activation in human bronchial epithelial cells. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20889674
Brochu-Bourque A et al. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor. 2011 J. Pharmacol. Exp. Ther. pmid:20966037
Xu L et al. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings. 2010 Pharmazie pmid:21105577
Dartt DA et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. 2011 J. Immunol. pmid:21357260
Huang SC Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum. 2011 Life Sci. pmid:21396378
Haneda Y et al. Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages. 2011 Cytokine pmid:21482134
Cai BL et al. [Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells]. 2011 Zhejiang Da Xue Xue Bao Yi Xue Ban pmid:21488208
Daniele S et al. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. 2011 J. Pharmacol. Exp. Ther. pmid:21531793
Chen LY et al. Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes. 2011 Allergy pmid:21605126
Rehni AK and Singh TG Modulation of leukotriene D4 attenuates the development of seizures in mice. 2011 Prostaglandins Leukot. Essent. Fatty Acids pmid:21641195
Mizutani N et al. Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis. 2012 Phytother Res pmid:21698671
Luo H et al. [Changes of leukotriene D4 in nasal discharge and plasma of patients with persistent allergic rhinitis and the effects of antihistamine]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21761705
Ni NC et al. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice. 2011 J. Pharmacol. Exp. Ther. pmid:21903747
Drost AC et al. The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. 2012 Leuk. Lymphoma pmid:21936770
Matsumoto H et al. Interleukin-13 enhanced Ca2+ oscillations in airway smooth muscle cells. 2012 Cytokine pmid:22078634
Ahmed T et al. Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence. 2012 Respir. Res. pmid:22269021
Muccitelli RM et al. Cysteinyl leukotriene receptor assays. 2001 Curr Protoc Pharmacol pmid:22293965
Dannull J et al. Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. 2012 Blood pmid:22323449
Rehn M and Diener M Cysteinyl leukotrienes mediate the response of submucosal ganglia from rat colon to bradykinin. 2012 Eur. J. Pharmacol. pmid:22366210
Parmentier CN et al. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1. 2012 J. Allergy Clin. Immunol. pmid:22391114
Guan W et al. Leukotriene D4 bronchial provocation test: methodology and diagnostic value. 2012 Curr Med Res Opin pmid:22435894
Dahlén B et al. Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma. 2012 Eur. J. Clin. Pharmacol. pmid:22457014
Forsell PK et al. Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases. 2012 Lipids pmid:22684912
Huang XQ et al. Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1. 2012 J Neuroinflammation pmid:22734808
Pelclová D et al. Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis. 2012 Ind Health pmid:22785421
Provost V et al. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells. 2012 PLoS ONE pmid:22952702
Tang SS et al. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice. 2013 Neuropharmacology pmid:22982445
Guan W et al. Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes. 2013 J. Allergy Clin. Immunol. pmid:23040886
Celik D et al. Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics. 2013 Clin. Chem. Lab. Med. pmid:23045385
Wan D et al. The effects of montelukast on eosinophilic gastroenteritis in a mouse model. 2013 Immunopharmacol Immunotoxicol pmid:23240855
Wang XY et al. Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons. 2013 Neurochem. Int. pmid:23318673
Germain AR et al. Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. 2013 Bioorg. Med. Chem. Lett. pmid:23403082
Jørgensen ST et al. Double mutation at the putative protein kinase C phosphorylation sites Thr151 plus Thr323 in the mouse leukotrieneD4 receptor eliminates homologous desensitization. 2013 Cell. Physiol. Biochem. pmid:23485744
Kanaoka Y et al. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. 2013 J. Biol. Chem. pmid:23504326
Kumasawa F et al. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells. 2013 Asian Pac. J. Allergy Immunol. pmid:23517395
Ramos-Ramírez P et al. Antigen-induced airway hyperresponsiveness in absence of broncho-obstruction in sensitized guinea pigs. 2013 Exp. Lung Res. pmid:23527782
Rodríguez-Lagunas MJ et al. 5-Hydroxyeicosatetraenoic acid and leukotriene D4 increase intestinal epithelial paracellular permeability. 2013 Int. J. Biochem. Cell Biol. pmid:23583294
Syslová K et al. Immunomagnetic molecular probe with UHPLC-MS/MS: a promising way for reliable bronchial asthma diagnostics based on quantification of cysteinyl leukotrienes. 2013 Jul-Aug J Pharm Biomed Anal pmid:23644905
Doherty TA et al. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. 2013 J. Allergy Clin. Immunol. pmid:23688412